?Studing the effect of Nano-curcumin and curcumoup in primary dysmenorrhea

Comparing the effect of nano-Curcumin with Curcumin and control group on primary dysmenorrhea among 18-27 years old women

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160813029327N11

Enrollment

180

Registered

2018-05-27

Start date

2018-04-15

Completion date

Unknown

Last updated

2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysenorrhea. Primary dysmenorrhoea

Interventions

Intervention 1: Intervention group 1: first intervention group is nano-curcumin group. This medicine in the form of 80 mg soft gelatin capsule will be consumed once daily by oral route for the first t

Eligibility

Sex/Gender

Female

Age

18 Years to 27 Years

Inclusion criteria

Inclusion criteria: having primary dysmenorrhea age of 18-27 Informed consent

Exclusion criteria

Exclusion criteria: pregnancy and lactation hypersensitivity to the Curcumin products using other drugs asthma, GI tract diseases, cholelithiasis and obstruction of gull duct intolerance of NSAIDs using anti-coagulant agents developing ovarian cysts using OCPs

Design outcomes

Primary

Measure	Time frame
Intensity of pain in primary dysmenorrhea. Timepoint: The measurement of intensity of pain, in first 3 days of 4 consecutive menstural period. Method of measurement: Visual Analogue Scale and quality of life questionnaire.	—

Secondary

Measure	Time frame
Quantity of Mefenamic acid. Timepoint: Patients in first month will just use Mefenamic acid and in three following months will use mefenamic acid besides study drugs if it is necessary. Method of measurement: By questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRamin Abrishami

Islamic Azad University

r_abrishami@iaups.ac.ir+98 21 2264 1889

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026